PROTO, MARIA CHIARA
 Distribuzione geografica
Continente #
EU - Europa 22
NA - Nord America 11
AS - Asia 9
Totale 42
Nazione #
US - Stati Uniti d'America 11
FR - Francia 6
GB - Regno Unito 4
IT - Italia 4
NL - Olanda 3
CZ - Repubblica Ceca 2
IN - India 2
LB - Libano 2
UA - Ucraina 2
YE - Yemen 2
ID - Indonesia 1
JO - Giordania 1
SE - Svezia 1
SG - Singapore 1
Totale 42
Città #
Ashburn 4
Bermondsey 3
Columbus 3
Council Bluffs 2
Mumbai 2
Sanaa 2
Amman 1
Amsterdam 1
London 1
Nocera Superiore 1
Rome 1
Surabaya 1
Totale 22
Nome #
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer, file e2915b35-21bd-8981-e053-6605fe0a83a3 19
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids, file e2915b35-9167-8981-e053-6605fe0a83a3 14
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux, file e2915b35-ad91-8981-e053-6605fe0a83a3 5
The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity., file e2915b30-ffd2-8981-e053-6605fe0a83a3 1
Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019, file e2915b35-6460-8981-e053-6605fe0a83a3 1
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux, file e2915b35-bdce-8981-e053-6605fe0a83a3 1
Tetra-substituted pyrrole derivatives act as potent activators of p53 in melanoma cells, file e2915b35-df79-8981-e053-6605fe0a83a3 1
Totale 42
Categoria #
all - tutte 323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2021/20222 0 0 0 0 0 0 0 0 1 0 1 0
2022/202311 0 0 0 1 1 2 0 1 1 1 4 0
2023/202428 3 4 4 1 0 0 6 5 0 0 5 0
Totale 42